MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$34,399
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from sale of marketable...
Options issued to directors
Options issued to non-employees
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Change in fair value of derivati...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-06-30
Options issued to non-employees
44,219
Options issued to directors
110,168
Net loss
-2,920,938
Prepaid expenses
445,773
Operating leases
0
Deferred compensation payable
0
Trade and other payables
-224,954
Change in fair value of warrants
0
Options issued to key employees
35,103
Loss on issuance of series g convertible preferred stock
0
Loss on issuance of series f-1 convertible preferred stock
0
(gain) on sale of marketable securities
2,176
Change in fair value of marketable securities
-1,744
Change in fair value of derivatives
1,303,000
Net cash used by operating activities
-4,705,607
Proceeds from sale of marketable securities
10,659,546
Purchases of marketable securities
5,919,540
Net cash provided by/(used in) investing activities
4,740,006
Redemption of series f convertible preferred stock
0
Proceeds from issuance of series f-1 convertible preferred stock
0
Proceeds from the issuance of series g convertible preferred stock
0
Dividends on preferred stock
0
Premium on series f convertible preferred stock
0
Net cash provided by financing activities
0
Net decrease in cash
34,399
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sale of
marketable securities
$10,659,546
Net cash provided
by/(used in) investing...
$4,740,006
Canceled cashflow
$5,919,540
Net decrease in cash
$34,399
Canceled cashflow
$4,705,607
Purchases of marketable
securities
$5,919,540
Options issued to
directors
$110,168
Options issued to
non-employees
$44,219
Options issued to key
employees
$35,103
Change in fair value of
marketable securities
-$1,744
Net cash used by
operating activities
-$4,705,607
Canceled cashflow
$191,234
Net loss
-$2,920,938
Change in fair value of
derivatives
$1,303,000
Prepaid expenses
$445,773
Trade and other
payables
-$224,954
(gain) on sale of
marketable securities
$2,176
Buy us a coffee
TNF Pharmaceuticals, Inc. (TNFA)
TNF Pharmaceuticals, Inc. (TNFA)